Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What ethical challenges arise in global health programmes? A qualitative case study of global health programme leaders' experiences.

BMJ open·2025
Same author

Ethical issues in implementation science: perspectives from a National Heart, Lung, and Blood Institute workshop.

Implementation science : IS·2024
Same author

Target regimen profiles for tuberculosis treatment.

Bulletin of the World Health Organization·2024
Same author

The 6I model: an expanded 4I framework to conceptualise interorganisational learning in the global health sector.

BMJ open·2024
Same author

Community engagement and the centrality of 'working relationships' in health research.

BMJ global health·2024
Same author

Target product profiles: tests for tuberculosis treatment monitoring and optimization.

Bulletin of the World Health Organization·2023
Same journal

Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study.

The Lancet. Infectious diseases·2026
Same journal

Cefiderocol heteroresistance in NDM Enterobacterales.

The Lancet. Infectious diseases·2026
Same journal

Correction to Lancet Infect Dis 2020; 20: 37-59.

The Lancet. Infectious diseases·2026
Same journal

Correction to Lancet Infect Dis 2020; 20: 60-79.

The Lancet. Infectious diseases·2026
Same journal

Expert consensus on case definitions in human loiasis: a Delphi study.

The Lancet. Infectious diseases·2026
Same journal

The Bundibugyo virus disease outbreak: a warning signal for risks to health workers.

The Lancet. Infectious diseases·2026
See all related articles

Related Experiment Video

Updated: May 12, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Engaging communities in tuberculosis research.

Renaud F Boulanger1, Stephanie Seidel, Erica Lessem

  • 1Ethical, Social and Cultural Program, St Michael's Hospital, Toronto, ON, Canada.

The Lancet. Infectious Diseases
|March 28, 2013
PubMed
Summary
This summary is machine-generated.

Community engagement enhances clinical trial ethics and outcomes, particularly in tuberculosis research. Sharing lessons and developing assessment strategies are crucial for successful tuberculosis community engagement programs.

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Related Experiment Videos

Last Updated: May 12, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
10:41

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on: April 30, 2020

Area of Science:

  • Public Health
  • Clinical Trials
  • Medical Ethics

Background:

  • Community engagement is increasingly recognized for improving clinical trial ethics and outcomes.
  • While established in HIV/AIDS research, community engagement in tuberculosis research remains underdeveloped.
  • This article addresses the need for greater community involvement in tuberculosis clinical trials.

Purpose of the Study:

  • To highlight existing community engagement initiatives in tuberculosis research.
  • To identify resources supporting the implementation of community engagement programs in tuberculosis trials.
  • To advocate for enhanced community engagement in tuberculosis research.

Main Methods:

  • Review of existing community engagement initiatives in tuberculosis research.
  • Identification and discussion of resources, including the Good Participatory Practice guidelines for tuberculosis drug trials.
  • Analysis of needs for sharing lessons and developing formal assessment strategies.

Main Results:

  • Several community engagement initiatives in tuberculosis research exist.
  • The Good Participatory Practice guidelines offer a framework and practical guidance for engagement.
  • There is a need for shared lessons and formal assessment strategies to advance engagement.
  • Research funders and sponsors play a key role in resource allocation.

Conclusions:

  • Community engagement is vital for ethical and effective tuberculosis research.
  • Sharing best practices and implementing formal assessments are necessary next steps.
  • Leadership from funders and sponsors is essential for resource allocation and program success.